Cited by 884Cancer-related Molecular PathwaysCancer Genomics and DiagnosticsGenetic factors in colorectal cancer

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

Petitjean, A, Achatz, M I W, Borresen-Dale, A L, Hainaut, P, Olivier, M·2007·Oncogene

Open this paper in CoChat — free account

Abstract

A large amount of data is available on the functional impact of missense mutations in TP53 and on mutation patterns in many different cancers. New data on mutant p53 protein function, cancer phenotype and prognosis have recently been integrated in the International Agency for Research on Cancer TP53 database (http://www-p53.iarc.fr/). Based on these data, we summarize here current knowledge on the respective roles of mutagenesis and biological selection of mutations with specific functional characteristic in shaping the patterns and phenotypes of mutations observed in human cancers. The main conclusion is that intrinsic mutagenicity rates, loss of transactivation activities, and to a lesser extent, dominant-negative activities are the main driving forces that determine TP53 mutation patterns and influence tumor phenotype. In contrast, current experimental data on the acquisition of oncogenic activities (gain of function) by p53 mutants are too scarce and heterogenous to assess whether this property has an impact on tumor development and outcome. In the case of inherited TP53 mutations causing Li-Fraumeni and related syndromes, the age at onset of some tumor types is in direct relation with the degree of loss of transactivation capacity of missense mutations. Finally, studies on large case series demonstrate that TP53 mutations are independent markers of bad prognosis in breast and several other cancers, and that the exact type and position of the mutation influences disease outcome. Further studies are needed to determine how TP53 haplotypes or loss of alleles interact with mutations to modulate their impact on cancer development and prognosis.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1210302

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Surfing the p53 network
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“191117) encodes a transcription factor which is activated in response to several forms of cellular stress and exerts multiple, antiproliferative functions (Vogelstein et al., 2000).”
Background
Instability and decay of the primary structure of DNA
Lindahl, T. (1993) · Nature · doi:10.1038/362709a0 · Cited by 5,679
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Patterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559

Show all 117 references

Research works printed but not linked: 1

Langerod A, Burdette L, Yeager M, Llaca V, Presswalla S, Gerhard DS et al. (2006a). Pattern of genetic variation in the tp53 locus indicates linkage disequilibrium extends across the flanking genes, ATP1B2 and WDR79. Hum Mutat (in press).

Sorted by citations

Items 801–883 of 883

Association Between Arg72Pro Polymorphism in TP53 and Malignant Abdominal Solid Tumor Risk in Hunan Children
Liu, Z., Xiao, Z., Li, M., Xiao, Y., Wang, X., He, J., & Li, Y. (2021) · Cancer Control · doi:10.1177/10732748211004880
The Role of Introns for the Development of Inflammation-Mediated Cancer Cell
Begum, R., Asrafuzzaman, M., Rashid, M. T., & Nawar, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96754
Modelos murinos en el estudio del cáncer mamario
Luna, R. A. J., & Meza, J. M. G. (2020) · Revista Mexicana de Mastología · doi:10.35366/99157
Deciphering the roles of micro-environmental stress types in cancer initiation and progression
Zhang, C. (2015)
NOVEL COMPUTATIONAL METHODS FOR CANCER GENOMICS DATA ANALYSIS
Liu, J. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.215
Statistical Methods for the Analysis of Genomic Data
Jiang, H., & He, Z. (2020) · MDPI eBooks · doi:10.3390/books978-3-03936-141-0
Integrative bioinformatics analysis for identification of hub genes and pathways responsible for early pathogenesis of retinoblastomaPreprint
Karmakar, A., Khan, M. M. A., Kumari, N., & Ganesan, S. K. (2020) · doi:10.21203/rs.3.rs-30876/v1
Investigação de predisposição hereditária ao câncer em mulheres com câncer de endométrio proficientes para o sistema de reparo de malpareamento de DNA
de Santis, J. O. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-04082021-125326
Prognostic Value of Diverse TP53 Mutations in Metastatic Cancers: An Analysis of the Cbioportal DatabasePreprint
Liu, K., Yan, L., Wang, H., Jiao, X., Qin, B., Wu, Y., He, X., Duan, X.-P., Li, B., Zou, X. N., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3910363
Mutation Analysis and Single Nucleotide Polymorphism of TP53 Gene in Breast Cancer in East Java
Radhiyah, R., Ardana, I. K. K. G., Wisnubroto, W. W., Listyorini, D. I., & Susanto, H. (2021) · Journal of Tropical Life Science · doi:10.11594/jtls.11.03.12
Molecular Docking of the Cardenolides of Asclepias subulata in the Human p53 Protein Reveals an Interaction in the Cleft of the Y220C Mutant
Valenzuela-Chavira, I., Meneses-Sagrero, S. E., Arvizu-Flores, A. A., Hernández-Paredes, J., Rascón-Valenzuela, L. A., Velázquez, C. A., & Robles‐Zepeda, R. E. (2021) · Current Chemical Biology · doi:10.2174/2212796815666211026112056
Screening and Evaluating Novel Autoantibodies Based on Proteomic Chips in Diagnosis of Esophageal Squamous Cell CarcinomaPreprint
Han, Z., Wu, J., Sun, G., Cui, C., Qiu, C., Ye, H., Dai, L., Wang, K., Shi, J., & Wang, P. (2021) · Research Square · doi:10.21203/rs.3.rs-1085112/v1
Faculty Opinions recommendation of miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.
Khosravi‐Far, R., & Datta, D. B. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5601962.6178055
Faculty Opinions recommendation of Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Haupt, Y., & Haupt, S. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14254965.15769069
Li-Fraumeni Syndrome
Olivier, M., & Hainaut, P. L. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_3345
Self-citation
P53, Immunology
DeLeo, A. B., & Whiteside, T. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_30-4
P53, Immunology
DeLeo, A. B., & Whiteside, T. L. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_30
Li-Fraumeni Syndrome
Olivier, M., & Hainaut, P. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_3345
Self-citation
Cancer Genetics in the Clinic
(2007) · Springer eBooks · doi:10.1007/978-1-4020-6784-6_7
TP53
Kojima, K., & Andreeff, M. (2015) · Wiley eBooks · doi:10.1002/9781118468678.ch36
Faculty Opinions recommendation of Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.
Balasubramanian, M. K., & Chew, T. G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734608427.793554845
Li-Fraumeni Syndrome
Olivier, M., & Hainaut, P. L. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_3345
Self-citation
Analysis of the radio-pathological factors of triple negative breast cancer and determination of risk profiles
Sebastián, C. S., Mur, C. G., Bañeres, B. G., Ciria, S. C., Cuesta, D. S. R., & Amador, I. S. (2020) · Radiología (English Edition) · doi:10.1016/j.rxeng.2020.03.002
Li-Fraumeni Syndrome
Olivier, M., & Hainaut, P. L. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_3345-3
Self-citation
TERT Mutation was Associated with the Risk of Recurrence in Lung Adenocarcinoma with A Micropapillary PatternPreprint
Wang, F., Xu, L., Hao, Q., Li, C., Wu, Q., & Lu, H. (2020) · doi:10.21203/rs.3.rs-39789/v1
Li Fraumeni Syndrome
Gómez, F. R., Ibáñez, R. D. M., Serrano, A. M., Dominguez, T. P., & Sánchez, J. C. P. (2019) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2019.11.008
Machine learning enables accurate prediction of breast cancer five-year survival using somatic genomic variantsPreprint
Jiang, X., Zhang, L., Cao, G., Li, J., & Bai, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.22.492994
Reconstructing the functional effect of TP53 somatic mutations on its regulon using causal signalling network modellingPreprint
Triantafyllidis, C. P., Barberis, A., Miar, A., Gjerga, E., Charlton, P. V., Hartley, F., van Bijsterveldt, L., Sáez-Rodríguez, J., & Buffa, F. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.23.497293
Cancer Detection and Prognostication
Bunz, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-99387-0_9
TP53-status dependent oncogenic EZH2 Activity in Pancreatic Cancer
Versemann, L. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9359
Navigating Uncharted Waters: Could Certain COVID-19 Vaccines Promote Malignancy?Preprint
Angues, R. V., & Bustos, Y. P. (2022) · doi:10.22541/au.166358581.18921295/v1
p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities
Giono, L. E., Ladelfa, M. F., & Monte, M. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_4
Data from Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
der Plas, M. L.-V., Brakenhoff, R. H., Kuik, D. J., Buijze, M., Bloemena, E., Snijders, P. J. F., Leemans, C. R., & Braakhuis, B. J. M. (2023) · doi:10.1158/1078-0432.c.6519221.v1
Data from TP53 Cancerous Mutations Exhibit Selection for Translation Efficiency
Waldman, Y. Y., Tuller, T., Sharan, R., & Ruppin, E. (2023) · doi:10.1158/0008-5472.c.6500486
Data from Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
der Plas, M. L.-V., Brakenhoff, R. H., Kuik, D. J., Buijze, M., Bloemena, E., Snijders, P. J. F., Leemans, C. R., & Braakhuis, B. J. M. (2023) · doi:10.1158/1078-0432.c.6519221
Data from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
You, M., Wang, D., Liu, P., Vikis, H. G., James, M., Lü, Y., Wang, Y., Wang, M., Chen, Q., Jia, D., et al. (2023) · doi:10.1158/1078-0432.c.6517600.v1
Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice
Epstein, R. J., Lin, F. P. Y., Brink, R. A., & Blackburn, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284327
TP53 Arg72Pro Genetic Polymorphism and Young Women with Breast Cancer: Case-Control Study in Brazil
Santos, S. D. S., da Costa, R. S. S., Diniz, L. F., Ferreira, R. M., Jácome, G. P. O., & Koifman, R. J. (2023) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2023v69n2.3674
WITHDRAWN: Involvement of KMT2 (MLL) family of methyltransferases in head and neck squamous cell carcinoma: A systematic review
Santos, M. E. D. S., Abreu, A. K. D. C., da Silva, F. W. M., Ferreira, E. B., dos Reis, P. E. D., & Ramos, D. D. A. R. (2023) · Oral Oncology Reports · doi:10.1016/j.oor.2023.100058
Retracted
Machine Learning on the Free Energy Landscape of p53: Analyzing Protein Rescue Using Neural Networks
Kemal, N. (2023) · doi:10.14418/wes01.1.2766
Molecular genetic features of hereditary forms of breast cancer (systematic review)
Serebryakova, A. V., Aliev, K. A., Sorokina, L. E., Gritskevich, O. Y., & Zyablitskaya, E. Y. (2023) · Pharmacogenetics and Pharmacogenomics · doi:10.37489/2588-0527-2023-1-33-45
Anti-tumor activities of auricularia polytricha extracts in hepatocellular carcinoma cell line (HepG2) and breast cancer cell lines (MCF-7 AND MDA-MB-231)
Nilkhet, S. (2019) · doi:10.58837/chula.the.2019.145
Association of ESR1 germline variants with TP53 somatic variants in breast tumors in a genome-wide studyPreprint
Tjader, N. P., Beer, A. J., Ramroop, J. R., Tai, M.-C., Ping, J., Gandhi, T., Dauch, C., Neuhausen, S. L., Ziv, E., Sotelo, N., et al. (2023) · medRxiv · doi:10.1101/2023.12.06.23299442
Germ cell tumor treatment resistance and liquid biopsy-based microRNA biomarkers
Timmerman, D. M. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2055
Primary Extranodal Diffuse Large B-cell Lymphoma: Molecular Landscape, Antitumor Treatment and Prognosis
Mingalimov, M. A., Барях, Е. А., Мисюрина, Е. Н., Поляков, Ю. Ю., Zhelnova, E. I., Толстых, Т. Н., Чуднова, Т. С., Иванова, Д. Д., Kochneva, O. L., Зотина, Е. Н., et al. (2023) · Гематология Трансфузиология Восточная Европа · doi:10.34883/pi.2023.9.4.012
Molecular Dynamics Simulation of the Interaction of Saccharin with Human p53 Protein
Shahlaei, M., & Mansourian, M. (2023) · Armaghane Danesh · doi:10.61186/armaghanj.28.6.11
Additional file 2 of NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis
Zhang, J., Liu, J. J., McGillivray, P. D., Yi, C., Lochovsky, L., Lee, D., & Gerstein, M. (2020) · Figshare · doi:10.6084/m9.figshare.13141973
miRTarDS: High-Accuracy Refining Protein-level MicroRNA Target Interactions from Prediction Databases Using Sentence-BERTPreprint
Chen, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.17.594604
The Impact of Specific High-Pathogenic Tp53 Mutations on Survival in Head and Neck Cancers
Kaler, A. K., Thakur, S., Sateesh, K., Ghosh, M., & Rao, V. (2024) · Journal of Translational Medicine & Transplantation Research · doi:10.47363/jtmtr/2024(3)111
The R337C mutation in the p53 oligomerization domain affects the regulatory domain and its ability to bind response elements: Evidence based on structural and biophysical studies
Singh, A., Malhotra, L., Mishra, A., Kundral, S., Tiwari, P. K., Kumar, S., Hariprasad, G., Kaur, P., & Ethayathulla, A. S. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110381 · Cited by 1
Structure-Based Discovery of a Cryptic Druggable Pocket in TP53 C238Y: Implications for Targeted TherapyPreprint
shakeel, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6370188/v1
Histomorphological and Molecular Features of Colonic Large-Cell Neuroendocrine Carcinoma in a Patient With Familial Adenomatous Polyposis: A Case Report and Review of Literature
Moustafa, M., Xu, J., Wang, H., Peng, L., & Chi, Z. (2025) · International Journal of Surgical Pathology · doi:10.1177/10668969251346939
Presence of microscopic skipping growth pattern correlated with KRAS or GNAS mutations in pulmonary mucinous adenocarcinoma
Zhou, Y., Chen, L., Li, J., Zhang, H., Xiao, Y., Cai, Y., Wang, H., Zhen, Y., Liang, Z., & Shi, X. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156165
Understanding the molecular landscape of triple-negative breast cancer
Nazir, I., Garg, A., Singh, S. K., & Kothawade, S. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33565-5.00010-4
Sentinel Gene Within Cell Territory and Molecular Platforms in Cancer: Methylation Diversity of p53 Gene in Brain Tumors
Mehdipour, P., & Karami, F. (2015) · Springer eBooks · doi:10.1007/978-94-017-9639-2_8
Additional file 1 of NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis
Zhang, J., Liu, J. J., McGillivray, P. D., Yi, C., Lochovsky, L., Lee, D., & Gerstein, M. (2020) · Figshare · doi:10.6084/m9.figshare.13141970
Additional file 1 of Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer
Wang, L., Pan, S., Zhu, B., Yu, Z., & Wang, W. (2021) · Figshare · doi:10.6084/m9.figshare.14121708
Recent advances in detection techniques regarding predictive, prognostic, and diagnostic biomarkers in solid cancers and its future challenges
Tripathy, S., Gaur, A., Jagadeb, M., Swarup, V., Gupta, N. M., Kumar, U., Das, S., & Jana, M. K. (2026) · Advances in cancer research · doi:10.1016/bs.acr.2025.12.006
Targeting oncogenic pathways in multiple cancers using isolated bioactive compounds from Bergenia ciliata: A network pharmacology, molecular docking, molecular dynamics and in vitro study
Chakrabarty, S., Kumari, S., Kumar, S., Tripathi, N., Bhardwaj, N., Guru, S. K., Singh, B., Ramanathan, V., & Jain, S. K. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100195
Lung cancer-enriched p53 mutants occupy canonical p53 target genes without activating transcription, revealing a distinct loss-of-function behaviorPreprint
Tracewell, M., Shankle, H. N., Barnada, S. M., Vyas, K. S., Kim, K. M., Qyshkollari, T., Karlin, J., Barta, J. A., & McMahon, S. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.14.705936
Molecular origin, discovery, validation and application of neoantigens
Lyu, Q., & Hu, S. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101143 · Cited by 1
Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: a clinicopathological diagnostic study and molecular features
Yu, M., Jiang, M. H., Zhang, X., Chen, H., & Ye, X. (2026) · Diagnostic Pathology · doi:10.1186/s13000-026-01782-y
Physiopathologie de l'hypertension artérielle pulmonaire : rôles de la voie de signalisation TGF-β/ALK1/Endogline et de p53
Gore, B. (2010) · theses.fr (ABES) · doi:10.70675/c07bbc56zd023z4202z8e97z7449d29922c5
Etude de la fonction de HIPK1, sa régulation et son implication en oncologie
Rey, C. (2010) · theses.fr (ABES) · doi:10.70675/4d830220z8b4dz449fzac53zd4e99eac2d5b
Sénescence cellulaire et nouvelles approches thérapeutiques de l'hypertension artérielle pulmonaire
Mouraret, N. (2013) · theses.fr (ABES) · doi:10.70675/b2ae892dzafc0z4b55z9d55zb8908a6a07c7
N-terminal isoforms of the p53 tumour suppressor protein : effects on p53 transcriptional activity and expression in cutaneous melanoma
Hafsi, H. (2012) · theses.fr (ABES) · doi:10.70675/636eb035zeb70z452ez8b98z0fdc80a752bb
Thermodynamic resilience of wild-type p53 DNA-binding domain and its disruption by the R273H hotspot mutation: insights from REMD simulations
Zhao, Z., Wang, G., & Qian, Z. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d6cp00665e
The role of NEDD8 pathway in cell invasion and strategies for the use of NEDD8 inhibitors in the clinic
Malhab, L. J. B. (2016) · theses.fr (ABES) · doi:10.70675/a9a79207z0857z4ed5zb207z749cdceb9430
Caractérisation de l'axe intégrine α5β1/protéine p53 dans les gliobastomes humains : application à une thérapie ciblée anti-tumorale
Renner, G. (2016) · theses.fr (ABES) · doi:10.70675/deb4fa44ze885z42b5zbaf7zdb798d1b1b3a
Étude du rôle des facteurs de transcription ETV4 et ETV1 de la famille ETS dans le processus tumoral de cancers hormono-dépendants : le cancer du sein, la progression métastatique du cancer de la prostate
Dumortier, M. (2017) · theses.fr (ABES) · doi:10.70675/ab740ce6z8d46z4df1za801z1946114ca584
Identification par séquençage de l'exome de la dérégulation des voies de signalisation dans le myélome multiple et leurs conséquences fonctionnelles, notamment sur la voie p53
Tessoulin, B. (2018) · theses.fr (ABES) · doi:10.70675/07321990z15cbz44b0zba91zeee1f3067f1f
Glioblastoma resistance to temozolomide : implication of α5β1 integrin and p53 signalling pathways
Sani, S. (2020) · theses.fr (ABES) · doi:10.70675/9566c585z0508z455bz9064z6bb61435b210
Développement d'une stratégie thérapeutique innovante dans la lutte contre les cancers métastatiques en utilisant le protozoaire Neospora caninum
Battistoni, A. (2023) · theses.fr (ABES) · doi:10.70675/4d26d9d1zc635z4966z9a3fz779716bb8f77
Network Pharmacology, Molecular Docking and Dynamics Simulation Reveal the Anti-Colitis Mechanism of Smilax glabra Roxb.
Cui, Y., Hu, J., Li, Y., Tong, Y., & Shen, H. (2026) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s595836
Neo-protein-protein interaction rewires oncogenic BRAF mutations to the p53 tumor-suppressor machinery
Niu, Q., Niu, L., Kariuki, J., Fan, D., Bai, R., Li, J., Lee, H., Fleming, P., (14951413), S. S. R., Ivanov, A. A., et al. (2026) · ASPET Discovery · doi:10.1016/j.aspetd.2026.100027
The impact of sex and gender on nonreproductive cancers
Jackson, S. S., Berner, A., Waite, K. A., & Barnholtz‐Sloan, J. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00066-4
p53-R280S mutation confers lenvatinib resistance in hepatocellular carcinoma via Bcl-2-mediated anti-apoptotic signaling
Cheng, N., Liu, K., Qi, X., Ls, C., Zhou, Y., Wang, F., Zhao, B., & Wang, Y. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05650-7
Uterine Carcinosarcoma: Mutational Profiling of p53-Abnormal Tumors and Its Association with Histologic Subtypes and Survival in an Underserved Population
Zhou, J., Yassa, M. E., Yu, D., & Chavarria, H. (2026) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000001214
Transcriptomic Profiling of Laser Capture Microdissected FFPE Esophageal Tissues Identifies Candidate Genes and Pathways Associated with Esophageal Adenocarcinoma
Hassan, S., Guggenbiller, M. J., Ritter, A., Heffernan, E., Li, J., Yan, M., Awasthi, N., & von Holzen, U. W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188164
Inhibition of RNA-m6A Methylation in Breast Cancer Cells Carrying TP53 R273H Mutant Reactivates Natural Killer Cells for Anticancer Immunity
Amin, M. N., Mostaq, M. S., Jois, S. D. S., Kang, L., & Liu, Y. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48101021
BindingDB Entry 50030665: Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.
BindingDB (2010) · UC San Diego · doi:10.7270/q2zk5grq
BindingDB Entry 50009545: The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series.
BindingDB (2021) · UC San Diego · doi:10.7270/q29p353v
Tumor Suppressor P53 Gene Mutations Pattern Induced by Repeated Fried Palm Oil in Rats
Hassanin, A. A. I., Hassan, A. G. A., Ali, S., & Itakura, T. (2014) · American Journal of Animal and Veterinary Sciences · doi:10.3844/ajavsp.2014.230.238

Authors: Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M.
Affiliations: Centre international de recherche sur le cancer (FR)
Corresponding author: Hainaut, P
ORCID: Petitjean, A
Achatz, M I W
Hainaut, P
Olivier, M
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2007-04-02
Volume: 26
Issue: 15
Pages: 2157-2165
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1210302
OpenAlex: W2042484101
Cited by: 884
References: 117
Citations by year: 2026: 16 · 2025: 29 · 2024: 29 · 2023: 50 · 2022: 55 · 2021: 52 · 2020: 50 · 2019: 53 · 2018: 60 · 2017: 46 · 2016: 57 · 2015: 52 · 2014: 53 · 2013: 43 · 2012: 48
FWCI: 5.08
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords: TP53 mutation, missense mutations, dominant-negative p53, gain-of-function, mutagenesis, tumor phenotype, cancer prognosis, Li-Fraumeni syndrome, loss of heterozygosity, breast cancer
MeSH terms: Genetic Markers, Humans, Mutation, Neoplasms, Polymorphism, Genetic, Prognosis, Biomarkers, Tumor, Tumor Suppressor Protein p53, Mutagenesis, Li-Fraumeni Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks